Evidence map›Paper›PMID 35760038›Full record

ArticleAnalytical chemistry2022

Measuring Thousands of Single-Vesicle Leakage Events Reveals the Mode of Action of Antimicrobial Peptides.

Kareem Al Nahas, Marcus Fletcher, Katharine Hammond, Christian Nehls, Jehangir Cama, Maxim G Ryadnov, Ulrich F Keyser

Abstract read
In one paragraph

Article in Analytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kareem Al NahasCavendish Laboratory, University of Cambridge, J.J. Thomson Avenue, Cambridge CB3 0HE, U.K.ORCID 0000-0003-4568-5894
Marcus FletcherCavendish Laboratory, University of Cambridge, J.J. Thomson Avenue, Cambridge CB3 0HE, U.K.ORCID 0000-0003-3036-1168
Katharine HammondNational Physical Laboratory, Hampton Road, Teddington TW11 0LW, U.K.ORCID 0000-0002-3755-6489
Christian NehlsResearch Center Borstel, Leibniz Lung Center, Parkallee 10, Borstel 23845, Germany.ORCID 0000-0002-9210-3271
Jehangir CamaCavendish Laboratory, University of Cambridge, J.J. Thomson Avenue, Cambridge CB3 0HE, U.K.ORCID 0000-0002-5982-1941
Maxim G RyadnovNational Physical Laboratory, Hampton Road, Teddington TW11 0LW, U.K.ORCID 0000-0003-4847-1154
Ulrich F KeyserCavendish Laboratory, University of Cambridge, J.J. Thomson Avenue, Cambridge CB3 0HE, U.K.ORCID 0000-0003-3188-5414

Funding

Wellcome TrustWellcome Trust 204909/Z/16/Z
6 · The paper itself

Abstract

Host defense or antimicrobial peptides hold promise for providing new pipelines of effective antimicrobial agents. Their activity quantified against model phospholipid membranes is fundamental to a detailed understanding of their structure-activity relationships. However, classical characterization assays often lack the ability to achieve this insight. Leveraging a highly parallelized microfluidic platform for trapping and studying thousands of giant unilamellar vesicles, we conducted quantitative long-term microscopy studies to monitor the membrane-disruptive activity of archetypal antimicrobial peptides with a high spatiotemporal resolution. We described the modes of action of these peptides via measurements of the disruption of the vesicle population under the conditions of continuous peptide dosing using a range of concentrations and related the observed modes to the molecular activity mechanisms of these peptides. The study offers an effective approach for characterizing membrane-targeting antimicrobial agents in a standardized manner and for assigning specific modes of action to the corresponding antimicrobial mechanisms.

Indexed as

Anti-Infective AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesPhospholipidsUnilamellar LiposomesAnti-Infective AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesPhospholipidsUnilamellar Liposomes

Identifiers

PMID35760038
PMCPMC9280716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.